Research news news
McGill University scientists, led by Ajjamada Kushalappa of the Faculty of Agricultural and Environmental Sciences, have teamed up with researchers from the Universidad Nacional de Colombia to develop nutritious, high-yielding, and more disease-resistant potatoes for food-insecure indigenous communities in Colombia.
Desautels Professor Francesca Carrieri’s grant application to the Social Sciences and Humanities Research Council (SSHRC) Insight Grants, entitled: "Financial Integration through History: Canada, the US and other Industrialized Countries," was ranked 1st out of 139 applications to Committee 435-3A this year.
Cachexia, a syndrome characterized by rapid weight loss and muscle deterioration, is a major cause of death among patients suffering from diseases like cancer, AIDS and chronic infection. Now, a newly published study by McGill University researchers shows that a low dose of Pateamine A is effective at preventing cancer-induced muscle wasting, which may lead to cachexia-fighting drugs.
We use a detailed panel data set of Swedish households to investigate the relation between their labor income risk and financial investment decisions. In particular, we relate changes in wage volatility to changes in the portfolio holdings for households that switched industries between 1999 and 2002. We find that households do adjust their portfolio holdings when switching jobs.
Two McGill researchers were recently awarded large partnership grants by the Social Sciences and Humanities Research Council (SSHRC). These grants are designed to foster research partnerships among the academic, private, public and not-for-profit sectors.
Whether it is for research into clean energy sources, the future of wireless communication or a better understanding of the processes involved in language learning, over 160 established McGill researchers and more than 80 graduate students will benefit from support from the Natural Sciences and Engineering Research Council of Canada (NSERC) over the next five years.
Creativity, teamwork, determination (possibly accompanied by blood, sweat and tears) are some of the skills honed by grade 6 – 8 students participating in the All Science Challenge, a unique, one-day, highly charged competition hosted by Let’s Talk Science on May 25 at The Neuro- the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre.
Attackers' private information is one of the main issues in defensive resource allocation games in homeland security. The outcome of a defense resource allocation decision critically depends on the accuracy of estimations about the attacker's attributes. However, terrorists' goals may be unknown to the defender, necessitating robust decisions by the defender.
This article explores the use of favors by emerging market managers, the impact of using favors on their firms' growth, legitimacy, and reputation in a variety of business environments, and how the use of favors affects firms' paths to international expansion.
This article studies the effects of product class and seller reputation on price-setting in online auctions. Sellers may offer price information to potential bidders through buy-now prices (BNPs) and starting prices (SPs). In two experiments, the authors show that for products with values that are difficult to assess, such price information affects bidders perception and willingness to pay.
“Don’t be safe, be brilliant” a saying by philosopher George Santayana was a favourite of world-renowned scientist Dr. David Colman, late director of the Montreal Neurological Institute and Hospital at McGill University and McGill University Health Centre.
Thanks to the Cole Foundation, pediatric leukemia research has again this year received support to recruit some of the best and brightest researchers in the field.
More than 50 members of The Neuro's staff are conducting laboratory and clinical studies related to MS. They employ the finest scientific equipment--from brain imaging scanners to the latest cell biology tools-to study the disease in all its aspects and at every stage. The Neuro's basic scientists and clinical physicians cooperate closely to translate research into patient therapies.